Adaptimmune Therapeutics Plc (ADAP) Annual Income Statement (USD)
ADAP Quarterly Financials (USD)
Frequently Asked Questions About Adaptimmune Therapeutics Plc (ADAP) Stock
Adaptimmune Therapeutics Plc's (ADAP) last reported annual revenue was USD 60.51 Million.
Adaptimmune Therapeutics Plc's (ADAP) annual revenue growth rate based on the revenue reported in the past 5 years is : 0.34%
Adaptimmune Therapeutics Plc's(ADAP) is not profitable as of its last reported annual financials.
The net profit margin for Adaptimmune Therapeutics Plc's(ADAP) from its laster reported year is -188.90%
The return on equity (ROE) for Adaptimmune Therapeutics Plc's(ADAP) from its last reported annual financials is : -187.61%
The return on assets (ROA) for Adaptimmune Therapeutics Plc's(ADAP) from its last reported annual financials is : -28.22%
The return on invested capital (ROIC) for Adaptimmune Therapeutics Plc's(ADAP) from its last reported annual financials is : -203.48%
The Debt to Equity ratio for Adaptimmune Therapeutics Plc's(ADAP) from its last reported annual financials is : 0.00%
The dividend yield for Adaptimmune Therapeutics Plc's(ADAP) from its laster reported year is 0.00%
Adaptimmune Therapeutics Plc's(ADAP) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ADAP !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
